BTIG analyst Ryan Zimmerman maintains $Penumbra (PEN.US)$ with a buy rating, and adjusts the target price from $234 to $232.
According to TipRanks data, the analyst has a success rate of 46.8% and a total average return of 1.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Penumbra (PEN.US)$'s main analysts recently are as follows:
Following Penumbra's third quarter earnings surpassing expectations, the company has successfully finished enrolling participants for its THUNDER trial and obtained FDA approval for its two new CAVT products, Lightning Bolt 6X and 12. Looking forward, the analyst anticipates that innovation within a significantly untapped market will propel the company towards a profile of double-digit revenue growth and substantial margin improvement.
The firm mentioned that the third quarter's revenue and operating margin surpassing expectations bolsters confidence in the company's capability to meet the revised full-year guidance and in the anticipated acceleration of growth in the following year, which is seen as vital for the stock's upward trajectory.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
BTIG分析師Ryan Zimmerman維持$Penumbra (PEN.US)$買入評級，並將目標價從234美元下調至232美元。
根據TipRanks數據顯示，該分析師近一年總勝率為46.8%，總平均回報率為1.1%。
此外，綜合報道，$Penumbra (PEN.US)$近期主要分析師觀點如下：
隨着penumbra第三季度收益超過預期，公司成功完成了THUNDER試驗的參與者招募，並獲得了其兩款新CAVt產品閃電6X和12的FDA批准。展望未來，分析師預計，在一個具有顯著未開發市場的創新中，將推動該公司實現兩位數的營業收入增長和實質性的利潤率改善。
公司提到第三季度的營業收入和營業利潤率超出預期，增強了對公司能夠實現修訂後全年指引以及預期在接下來一年內增長加速的信心，這被視爲股票向上軌跡至關重要。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
